Assessment of HIV transfusion transmission risk in South Africa: a 10-year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes
- PMID: 30265757
- PMCID: PMC10419327
- DOI: 10.1111/trf.14959
Assessment of HIV transfusion transmission risk in South Africa: a 10-year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes
Abstract
Background: In 1998 we estimated that 34/million infectious window period donations were entering the blood supply at the South African National Blood Service. Selective use of donations based on donor race-ethnicity reduced this risk to 26/million donations but was deemed unethical. Consequently, in 2005 South African National Blood Service eliminated race-ethnicity-based collection policies and implemented individual-donation nucleic acid testing (ID-NAT). We describe the change in donor base demographics, human immunodeficiency virus (HIV) detection rates, and transfusion-transmissible HIV risk.
Study design and methods: In ten years 7.7 million donations were tested for anti-HIV and HIV RNA. Number of donations, HIV prevalence, ID-NAT yield rate, serology yield rate and residual transfusion-transmissible HIV risk were analyzed by donor type, race-ethnicity, age, and sex. Multiple regression analysis was performed to investigate the determinants of HIV-positive and nucleic acid testing yield donations.
Results: The combined strategy of increasing donations from black donors and implementing ID-NAT increased the proportion of donations from black donors from 6% in 2005 to 30% in 2015 (p < 0.00001), and reduced the transfusion-transmissible risk from 24 to 13 per million transfusions. ID-NAT interdicted 481 (1:16,100) seronegative window period donations, while one transfusion-transmissible case (0.13 per million) was documented. Race-ethnicity and donor type were highly significant predictors of HIV positivity, with adjusted odds ratio for first-time donors of 12.5 (95% confidence interval, 11.9-13.1) and for black race-ethnicity of 31.1 (95% confidence interval, 28.9-33.4). The proportion of serology yields among HIV-infected donors increased from 0.27% to 2.4%.
Conclusion: ID-NAT enabled the South African National Blood Service to increase the number of donations from black donors fivefold while enhancing the safety of the blood supply.
© 2018 AABB.
Conflict of interest statement
Conflicts of interest: Nico Lelie may be paid by Grifols, the manufacturer of the NAT assay used, for review of the draft paper
There are no conflicts of interest for all other authors
Figures




Comment in
-
Technical solutions to social issues?Transfusion. 2019 Jan;59(1):9-11. doi: 10.1111/trf.15081. Transfusion. 2019. PMID: 30615812 No abstract available.
Similar articles
-
Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.Vox Sang. 2003 Jul;85(1):9-19. doi: 10.1046/j.1423-0410.2003.00311.x. Vox Sang. 2003. PMID: 12823725
-
Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.Transfusion. 2009 Jun;49(6):1115-25. doi: 10.1111/j.1537-2995.2009.02110.x. Epub 2009 Feb 27. Transfusion. 2009. PMID: 19309474
-
Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing.Vox Sang. 2005 Oct;89(3):128-34. doi: 10.1111/j.1423-0410.2005.00686.x. Vox Sang. 2005. PMID: 16146504
-
Direct comparison of three residual risk models for hepatitis B virus window period infections using updated input parameters.Vox Sang. 2020 Apr;115(3):133-145. doi: 10.1111/vox.12889. Epub 2020 Jan 20. Vox Sang. 2020. PMID: 31960480 Review.
-
[Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].Clin Lab. 2014;60(4):S1-39. doi: 10.7754/clin.lab.2014.140210. Clin Lab. 2014. PMID: 24779310 Review. German.
Cited by
-
Molecular dynamic simulations to investigate the structural impact of known drug resistance mutations on HIV-1C Integrase-Dolutegravir binding.PLoS One. 2020 May 7;15(5):e0223464. doi: 10.1371/journal.pone.0223464. eCollection 2020. PLoS One. 2020. PMID: 32379830 Free PMC article.
-
Implementation of a script for predonation interviews: impact on human immunodeficiency virus risk in South African blood donors.Transfusion. 2019 Jul;59(7):2344-2351. doi: 10.1111/trf.15288. Epub 2019 Apr 4. Transfusion. 2019. PMID: 30946490 Free PMC article.
-
HIV incidence in South African blood donors from 2012 to 2016: a comparison of estimation methods.Vox Sang. 2021 Jan;116(1):71-80. doi: 10.1111/vox.12987. Epub 2020 Aug 6. Vox Sang. 2021. PMID: 32762088 Free PMC article.
-
Undisclosed HIV status and antiretroviral therapy use among South African blood donors.Transfusion. 2021 Aug;61(8):2392-2400. doi: 10.1111/trf.16571. Epub 2021 Jul 5. Transfusion. 2021. PMID: 34224581 Free PMC article.
-
Health economic implications of testing blood donors in South Africa for HTLV 1 & 2 infection.Vox Sang. 2019 Jul;114(5):467-477. doi: 10.1111/vox.12788. Epub 2019 May 26. Vox Sang. 2019. PMID: 31131453 Free PMC article.
References
-
- Statistics South Africa -Mid Year population estimates. Statistical release 2017;http://www.statssa.gov.za/publications/P0302/P03022017.pdf.
-
- Heyns Adu P Risk of transmitting HIV and other diseases with a blood transfusion in South Africa. . CME (South African med assoc) 1999: 854–61.
-
- Heyns Adu P, Benjamin RJ, Swanevelder JP, Laycock ME, Pappalardo BL, Crookes RL, Wright DJ, Busch MP. Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa. JAMA 2006;295: 519–26. - PubMed
-
- Fang CT, Field SP, Busch MP, Heyns Adu P. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing. Vox Sang 2003;85: 9–19. - PubMed
-
- Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion 2009;49: 1115–25. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical